81 related articles for article (PubMed ID: 26213291)
1. Low-Intensity Ultrasound Promotes Clathrin-Dependent Endocytosis for Drug Penetration into Tumor Cells.
Tardoski S; Gineyts E; Ngo J; Kocot A; Clézardin P; Melodelima D
Ultrasound Med Biol; 2015 Oct; 41(10):2740-54. PubMed ID: 26213291
[TBL] [Abstract][Full Text] [Related]
2. Bone metastasis targeting: a novel approach to reach bone using Zoledronate anchored PLGA nanoparticle as carrier system loaded with Docetaxel.
Ramanlal Chaudhari K; Kumar A; Megraj Khandelwal VK; Ukawala M; Manjappa AS; Mishra AK; Monkkonen J; Ramachandra Murthy RS
J Control Release; 2012 Mar; 158(3):470-8. PubMed ID: 22146683
[TBL] [Abstract][Full Text] [Related]
3. Liposome encapsulation of zoledronic acid results in major changes in tissue distribution and increase in toxicity.
Shmeeda H; Amitay Y; Tzemach D; Gorin J; Gabizon A
J Control Release; 2013 May; 167(3):265-75. PubMed ID: 23419948
[TBL] [Abstract][Full Text] [Related]
4. Bone substitute materials delivering zoledronic acid: physicochemical characterization, drug load, and release properties.
Sörensen TC; Arnoldi J; Procter P; Robioneck B; Steckel H
J Biomater Appl; 2013 Feb; 27(6):727-38. PubMed ID: 22090432
[TBL] [Abstract][Full Text] [Related]
5. Efficient Gene Delivery by Sonoporation Is Associated with Microbubble Entry into Cells and the Clathrin-Dependent Endocytosis Pathway.
Delalande A; Leduc C; Midoux P; Postema M; Pichon C
Ultrasound Med Biol; 2015 Jul; 41(7):1913-26. PubMed ID: 25929996
[TBL] [Abstract][Full Text] [Related]
6. Low-intensity continuous ultrasound triggers effective bisphosphonate anticancer activity in breast cancer.
Tardoski S; Ngo J; Gineyts E; Roux JP; Clézardin P; Melodelima D
Sci Rep; 2015 Nov; 5():16354. PubMed ID: 26578234
[TBL] [Abstract][Full Text] [Related]
7. A once-yearly IV bisphosphonate for osteoporosis.
Med Lett Drugs Ther; 2007 Nov; 49(1273):89-90. PubMed ID: 17975523
[No Abstract] [Full Text] [Related]
8. Ultrasound-mediated drug/gene delivery in solid tumor treatment.
Zhou Y
J Healthc Eng; 2013; 4(2):223-54. PubMed ID: 23778013
[TBL] [Abstract][Full Text] [Related]
9. In Vitro Investigation of the Individual Contributions of Ultrasound-Induced Stable and Inertial Cavitation in Targeted Drug Delivery.
Gourevich D; Volovick A; Dogadkin O; Wang L; Mulvana H; Medan Y; Melzer A; Cochran S
Ultrasound Med Biol; 2015 Jul; 41(7):1853-64. PubMed ID: 25887690
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of a single dose of zoledronate in healthy dogs.
Martín-Jiménez T; De Lorimier LP; Fan TM; Freise KJ
J Vet Pharmacol Ther; 2007 Oct; 30(5):492-5. PubMed ID: 17803746
[No Abstract] [Full Text] [Related]
11. [Substance properties of zoledronate make it possible: bisphosphonate therapy only once yearly].
MMW Fortschr Med; 2006 Jun; 148(25):60-1. PubMed ID: 16859169
[No Abstract] [Full Text] [Related]
12. New self-assembly nanoparticles and stealth liposomes for the delivery of zoledronic acid: a comparative study.
Marra M; Salzano G; Leonetti C; Porru M; Franco R; Zappavigna S; Liguori G; Botti G; Chieffi P; Lamberti M; Vitale G; Abbruzzese A; La Rotonda MI; De Rosa G; Caraglia M
Biotechnol Adv; 2012; 30(1):302-9. PubMed ID: 21741464
[TBL] [Abstract][Full Text] [Related]
13. Zoledronic acid in combination with alfacalcidol has additive effects on trabecular microarchitecture and mechanical properties in osteopenic ovariectomized rats.
Khajuria DK; Razdan R; Mahapatra DR
J Orthop Sci; 2014 Jul; 19(4):646-56. PubMed ID: 24668309
[TBL] [Abstract][Full Text] [Related]
14. Delivery of zoledronic acid encapsulated in folate-targeted liposome results in potent in vitro cytotoxic activity on tumor cells.
Shmeeda H; Amitay Y; Gorin J; Tzemach D; Mak L; Ogorka J; Kumar S; Zhang JA; Gabizon A
J Control Release; 2010 Aug; 146(1):76-83. PubMed ID: 20462513
[TBL] [Abstract][Full Text] [Related]
15. Self-assembly nanoparticles for the delivery of bisphosphonates into tumors.
Salzano G; Marra M; Porru M; Zappavigna S; Abbruzzese A; La Rotonda MI; Leonetti C; Caraglia M; De Rosa G
Int J Pharm; 2011 Jan; 403(1-2):292-7. PubMed ID: 21055454
[TBL] [Abstract][Full Text] [Related]
16. Uptake of free, calcium-bound and liposomal encapsulated nitrogen containing bisphosphonates by breast cancer cells.
Zlatev HP; Auriola S; Mönkkönen J; Määttä JA
Eur J Pharm Sci; 2016 Apr; 86():58-66. PubMed ID: 26957415
[TBL] [Abstract][Full Text] [Related]
17. Recruitment of endocytosis in sonopermeabilization-mediated drug delivery: a real-time study.
Derieppe M; Rojek K; Escoffre JM; de Senneville BD; Moonen C; Bos C
Phys Biol; 2015 Jun; 12(4):046010. PubMed ID: 26118644
[TBL] [Abstract][Full Text] [Related]
18. Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair.
Amanat N; McDonald M; Godfrey C; Bilston L; Little D
J Bone Miner Res; 2007 Jun; 22(6):867-76. PubMed ID: 17371160
[TBL] [Abstract][Full Text] [Related]
19. Skeletal remodeling following clinically relevant radiation-induced bone damage treated with zoledronic acid.
Hui SK; Fairchild GR; Kidder LS; Sharma M; Bhattacharya M; Jackson S; Le C; Yee D
Calcif Tissue Int; 2012 Jan; 90(1):40-9. PubMed ID: 22083107
[TBL] [Abstract][Full Text] [Related]
20. Additive/synergistic antitumoral effects on prostate cancer cells in vitro following treatment with a combination of docetaxel and zoledronic acid.
Ullén A; Lennartsson L; Harmenberg U; Hjelm-Eriksson M; Kälkner KM; Lennernäs B; Nilsson S
Acta Oncol; 2005; 44(6):644-50. PubMed ID: 16165924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
